National Vision, a leading provider of eyewear and vision care services, outlined its strategy to build a cohesive vision-care platform at Barclays’ 19th Annual Global Consumer Conference on September 9, 2026. The company, which operates nearly 1,280 stores across 40 U.S. states and employs over 2,000 optometrists, is focusing on digital transformation, store expansion, and operational leverage to drive profitability and revenue growth through 2030.
The push comes as the company aims to nearly double its operating margin dollars from 2024 to 2026, with an average annual expansion of 50 to 150 basis points through 2030. Revenue growth is projected in the high single digits over five years, supported by comparable store sales growth in the mid-single digits. While gross margins are expected to remain flat to slightly dilutive, the bulk of margin improvement will stem from savings in SG&A expenses, particularly through procurement and sourcing efficiencies.
National Vision’s digital commerce capabilities are central to its vision-care platform strategy. All brands migrated to the Adobe e-commerce platform in Q2 2025, and full integration of unified commerce systems is targeted within 12 months of the conference. The company also plans to expand its store footprint aggressively: 30 to 35 new locations annually from 2025 through 2027, with reacceleration to over 60 openings per year starting in 2028.
The strategy aligns with a long-term focus on resilience in a market where about 42% of customers use insurance or managed care for vision purchases—a segment the company describes as more stable than purely fashion-driven optical sales. CEO Alex Wilkes emphasized the importance of this segment, noting that it provides a more predictable revenue stream. He also highlighted the company’s ability to offer bundled services, such as online eyewear purchases with on-demand doctor visits, through brands like America’s Best and Pearle Vision.
National Vision’s stock has underperformed recently, declining 36.5% over the past six months and 34% year-to-date, trading around $16.98–$17.00. The market cap stands at $1.34 billion, with a P/E ratio of 27.32. Analysts cite a range of price targets from $20 to $35, though the company’s guidance reflects a cautious outlook on gross margin stability. Despite the recent decline, the company’s operational focus on cost control and digital integration positions it for sustained growth in an evolving retail landscape.
The company’s financial performance in 2024 included a 3.5% operating margin and positive comparable store sales growth of 140 basis points in Q2 2025, underscoring its ability to balance expansion with efficiency. The Barclays presentation underscores a commitment to scaling its vision-care ecosystem while maintaining operational discipline, aiming to capitalize on the growing demand for integrated, tech-driven healthcare services.
